Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows Post author: Post published:June 4, 2024 Post category:uncategorized Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells. You Might Also Like FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients November 14, 2024 Keck Hospital of USC receives ninth “A” Hospital Safety Grade from The Leapfrog Group November 16, 2024 The fight against cancer: a comprehensive assessment of preventable and treatable cases September 29, 2023
Keck Hospital of USC receives ninth “A” Hospital Safety Grade from The Leapfrog Group November 16, 2024
The fight against cancer: a comprehensive assessment of preventable and treatable cases September 29, 2023